Skip to main content
Biophysical Journal logoLink to Biophysical Journal
. 2013 Sep 3;105(5):1227–1235. doi: 10.1016/j.bpj.2013.07.029

Effect of Proline Mutations on the Monomer Conformations of Amylin

Chi-cheng Chiu †,, Sadanand Singh §, Juan J de Pablo †,‡,
PMCID: PMC3762349  PMID: 24010666

Abstract

The formation of human islet amyloid polypeptide (hIAPP) is implicated in the loss of pancreatic β-cells in type II diabetes. Rat amylin, which differs from human amylin at six residues, does not lead to formation of amyloid fibrils. Pramlintide is a synthetic analog of human amylin that shares three proline substitutions with rat amylin. Pramlintide has a much smaller propensity to form amyloid aggregates and has been widely prescribed in amylin replacement treatment. It is known that the three prolines attenuate β-sheet formation. However, the detailed effects of these proline substitutions on full-length hIAPP remain poorly understood. In this work, we use molecular simulations and bias-exchange metadynamics to investigate the effect of proline substitutions on the conformation of the hIAPP monomer. Our results demonstrate that hIAPP can adopt various β-sheet conformations, some of which have been reported in experiments. The proline substitutions perturb the formation of long β-sheets and reduce their stability. More importantly, we find that all three proline substitutions of pramlintide are required to inhibit β conformations and stabilize the α-helical conformation. Fewer substitutions do not have a significant inhibiting effect.

Introduction

Amylin, or islet amyloid polypeptide (IAPP), is a peptide hormone that is coproduced with insulin by pancreatic β-cells (1,2). Human IAPP (hIAPP) consists of 37 residues, with a disulfide bridge between residues 2 and 7. The amyloid formation of hIAPP has been closely associated with the development of type II diabetes (1,3–7). It is believed that hIAPP amyloid deposits cause the loss of β-cells, thereby reducing insulin secretion (6,8–10).

Other species, including nonhuman primates, cats, and the degu, are also known to develop islet amyloid (3,11–14). In contrast, rat and mouse IAPPs are not amyloidogenic (15–17). As shown in Fig. 1, rat IAPP (rIAPP) contains 37 residues and differs from hIAPP at only six of these residues. Hence, rIAPP is often used as a proxy to study the mechanism and inhibition of hIAPP fibril formation (18,19). Out of these six residues, rIAPP has three proline residues, often referred to as β-sheet breakers, that greatly attenuate fibril formation (16,17). Based on this information, pramlintide, a synthetic human amylin analog, was designed to exhibit much reduced amyloidogenic properties. Pramlintide, also known as symlin, includes three proline substitutions at residues 25, 28, and 29, as seen in rIAPP (15,20). It has been used clinically in amylin replacement treatment for both type I and type II diabetes patients who take insulin (3,21,22).

Figure 1.

Figure 1

Sequence alignment with numbering based on hIAPP for various hIAPP derivatives, and IAPP of rat and species that form islet amyloid (11–14). Sequences of hIAPP, pramlintide, and two other hIAPP mutants are listed above the green dashed line. The proline mutations are marked with red, underlined fonts. The species variants of IAPP are given below the green dashed line, with the residues that differ from those in hIAPP marked in blue, underlined fonts.

Due to its amyloidogenic nature, it is difficult to study the conformational states of hIAPP in solution. Early in vitro circular dichroism (CD) studies found that hIAPP is mostly unstructured (23,24). More recent CD and NMR measurements, however, suggest that hIAPP exhibits a tendency to form an α-helix at the N-terminus region (residues 523), and that the C-terminus remains unstructured (25–29). Cort et al. (30) suggested that both hIAPP and pramlintide form an α-helix at the N-terminus, with pramlintide exhibiting a stronger helical content than hIAPP. It is believed that the N-terminal helix is responsible for receptor binding (1).

Just as the monomer conformation is poorly understood, little is known about the hIAPP fibril structure. Kajava et al. (31) proposed a three-strand model, with β-strands assigned to residues 1217, 2227, and 3137. Luca et al. (32) used solid-state NMR (ssNMR) to propose a strand-loop-strand morphology for hIAPP monomers in a fibril, where residues 817 and 2837 form β-sheets. Such a morphology is also supported by time-resolved two-dimensional IR (2DIR) and electron paramagnetic resonance (EPR) studies, with minor differences of one or two residues in the β-strand assignments (33,34). Wiltzius et al. (35) utilized fibril structures from the segments of residues 2127 and 2833 and relied on x-ray diffraction to propose a similar U-shape fibril structure, but with more closely interdigitated side chains compared with those inferred by ssNMR (32).

The central region of hIAPP, i.e., residues 2029, can independently form fibrils. That region has been proposed to be responsible for hIAPP amyloidogenic properties (36). The 2029 fragment also contains five out of the six differing residues between rIAPP and hIAPP, and it is often used as a model for studies of amyloid formation (37). Experiments have shown that one or more proline substitutions on such fragments at positions 25, 28, and 29 reduce fibril formation, with position 28 being the most critical (16,17). Additional studies have also demonstrated that fragments other than the central region, including 820, 1019, 3037, and 837, can form amyloid (38–40). Proline substitutions outside the central fragment also attenuate fibril formation (15,41).

Taken together, the studies cited above suggest that the aggregation of hIAPP involves a significant portion of the peptide, not just individual fragments. With that view in mind, in this work we investigated the effect of the proline substitutions encountered in pramlintide on the solution conformations of IAPP using the full peptide sequence. Recently, we used molecular dynamics (MD) and Monte Carlo simulations combined with Fourier-transform infrared (FTIR) spectrometry to study the conformations of full-length rIAPP and hIAPP monomers in dilute solution (42,43). Our data revealed that rIAPP adopts primarily two conformations: N-terminal α-helix and unstructured coil. In contrast, hIAPP was found to adopt three conformational states: N-terminal α-helix, β-hairpin, and unstructured coil. The β-hairpin conformation was shown to act as a possible precursor for amyloid formation (43–45). Simulations and time-resolved 2DIR have also been used to examine the structure of hIAPP fibrils as well as fibril formation in mixtures of hIAPP and rIAPP (18,33).

Here, we use MD and Monte Carlo simulations in the context of an advanced sampling technique, bias-exchange metadynamics (BE-Meta), to study the conformations of hIAPP and pramlintide in solution (46). BE-Meta has been successfully applied to study protein folding and the nucleation of small amyloid peptides (46–48). We also explore the conformations of two hIAPP derivatives, one having a proline substitution at residue 25 (hIAPP[A25P]) and the other having two proline substitutions at positions 28 and 29 (hIAPP[S28P,S29P]), and examine their structural stability.

Materials and Methods

Simulation details

Fig. 1 gives the amino acid sequences of hIAPP and the mutants considered in this work, namely, pramlintide, hIAPP[A25P], and hIAPP[S28P,S29P]. The C-terminal of each peptide was capped with an NH2 group, and a disulfide bond was formed to link the Cys2 and Cys7 residues. The amino acid side chains were ionized on the basis of their pKa values, and the resulting peptide had a net positive charge of +3 at pH 7. The corresponding chloride ions were added to the simulation box to neutralize the system. All peptides were modeled using the GROMOS96 53a6 force field along with the SPC water model (49–51). Such a combination was shown to provide agreement with experimental IR spectrum in previous studies of the rIAPP monomer, and the hIAPP monomer and its aggregates (18,33,42,43). The cutoff for van der Waals and short-range electrostatic interactions was 9 Å. Long-range electrostatic interactions were treated with a particle mesh Ewald sum (52,53). A linear constraint solver was used to keep all bonds at their respective equilibrium lengths (54). Temperature and pressure were controlled at 298 K and 1 bar using the Nose-Hoover thermostat and the Parrinello-Rahman barostat, respectively (55–58). All simulations were performed with an integration time step of 2 fs using the GROMACS 4.5 molecular simulation package (59). The system’s coordinates were saved every 10 ps for further analysis.

Collective variables

The peptide conformation was characterized using the αrmsd and anti-βrmsd collective variables (CVs) introduced by Pietrucci and Laio (60). The αrmsd is defined as

αrmsd=αn(RMSD), (1)
andn(RMSD)=1(RMSD/0.8)81(RMSD/0.8)12, (2)

where RMSD measures the root mean-square deviations, in angstroms, of the backbone N, Cα, C, O, and Cβ atom positions for every six consecutive residues in the peptide from those in an ideal α-helix (i.e., the average α-helical structure from the STRIDE database) (61). The function n(RMSD) switches smoothly between 0 and 1, and αrmsd sums over all possible six-consecutive-residue blocks. Larger αrmsd values indicate more ideal α-helical blocks. Similarly, the anti-βrmsd order parameter measures the RMSD values of the backbone atoms for every pair of three-residue blocks in the peptide sequence from those found in an ideal antiparallel β-sheet. Large anti-βrmsd values indicate more antiparallel β-strands in the structure.

For the particular case of hIAPP, we also used the number of native contacts, ncontact, in the α and β structures determined in our previous work (43) as two additional CVs to improve conformational sampling:

ncontact=i,jcontactnij, (3)
andnij={1forrij5.51(rij5.52.5)21(rij5.52.5)8forrij>5.5, (4)

where rij is the distance in angstroms between the Cα atoms of two residues that form hydrogen bonds (H-bonds) in the α or β conformations, nij, similar to n(RMSD) in Eq. 2, is a switching function between 0 and 1, and ncontact measures the number of Cα contacts of the α or β structures. The ncontact for the α structure accounts for all the i to i+4 residual contacts in the segment comprising residues 7–21. For the β structure, ncontact measures the Cα contacts between residue pairs (9,34), (10,33), (11,32), (12,31), (13,30), (14,29), (15,28), (16,27), (17,26), (18,25), and (19,24). For the other three hIAPP derivatives, due to lack of structural information, no native contact CVs and only two RMSD CVs were used to sample the peptide conformation.

Note that the main focus of this work is to evaluate the relative free energies of distinct hIAPP monomer conformations. Previous simulation studies relied on parallel tempering or replica-exchange techniques to explore hIAPP monomer conformations (43,44). Such studies revealed that hIAPP can adopt α-helical, β-hairpin, and random coil structures, where the antiparallel β-sheet is the main secondary structure in the β-hairpin conformation. Note that in the hIAPP mature fibril, peptides stack into in-register parallel β-sheets, not antiparallel ones. To further determine whether parallel β-sheets arise in the hIAPP monomer, we performed bias-exchange simulations with additional CVs, including intrapeptide H-bonds, dihedral angles, and Cγ contacts (see Supporting Material). The resulting free-energy profile as seen in Fig. S1 and Table S1 is consistent with that presented later in this work, in terms of only αrmsd and anti-βrmsd CVs. This finding provides additional evidence indicating that the hIAPP monomer by itself does not adopt a parallel β-sheet conformation.

BE-Meta simulations

To calculate the peptide conformational free energy with the CVs described above, we performed BE-Meta simulations (46) using the PLUMED plugin for GROMACS (62). The free-energy profiles were constructed using the METAGUI package for VMD (63,64). BE-Meta combines metadynamics and replica-exchange techniques (65–68) to enhance the sampling of various CVs. In metadynamics, a time-dependent bias is added to help the system escape local minima and enhance sampling. The bias added consists of a sum of Gaussian potentials (65):

VG(ξ,t)=Wttexp(i=1d[ξiξi(t)]22σi2), (5)

where VG(ξ,t) denotes the bias applied to the system at time t and CV values ξ=ξ1,ξ2,.ξd; d is the number of CVs used to guide the simulation; W and σ are the height and width, respectively, of each Gaussian; and ξi(t) is the ith CV at time t. In this work, W was 0.1 kJ/mol and σ was 0.5 for all CVs. Gaussian potentials were deposited every 1 ps. An exchange of configurations was attempted between two replicas every τex= 10 ps using Metropolis criteria (46):

pij=min(1,e[VGi(ξi,t)+VGj(ξj,t)VGi(ξj,t)VGj(ξi,t)]/kBT), (6)

where pij is the probability of accepting an exchange between replica i and j, kB is the Boltzmann constant, T is the temperature, ξx is the CV value in system x, and VGx(ξy,t) is the bias of system x corresponding to the CV value of system y at time t. In this study, for the case of two CVs, four replicas were employed. No bias was applied to the first replica. In the second and third replicas, Gaussian potentials were added to the first and second CVs, respectively. In the fourth replica, the bias acted simultaneously on both CVs.

After a certain amount of time tfill, most of the free-energy minima of the system in each replica were filled and VG fluctuated around an average profile. The free energy along the CV, ξ, can be approximated with the time average of VG(ξ,t) after tfill (69):

G(ξ)=1talltfilltfilltalldtG(ξ,t)=1talltfilltfilltalldtVG(ξ,t), (7)

where tall is the total simulation time, and G(ξ) is the system free energy as a function of ξ. The convergence of the free-energy profile in each replica was monitored using the protocol proposed by Marinelli et al. (47) and Biarnes et al. (63). As illustrated in Fig. 2, we calculated the average free energies corresponding to the time intervals (tfill,tall+tfill/2) and (tall+tfill/2,tall), for the replica with the αrmsd or anti-βrmsd bias using Eq. 7. For the filling time tall=200 ns, and the total simulation time tall=400 ns, the two average free-energy profiles are within 1 kBT of each other, indicating that our simulations are converged.

Figure 2.

Figure 2

Convergence of the free-energy profiles for hIAPP, pramlintide, hIAPP[A25P], and hIAPP[S29P,S29P] (from the top to the bottom row, respectively). The replicas with bias are plotted in the left column, and the ones with anti- are in the right column. Following the protocol described by Marinelli et al. (47) and Biarnes et al. (63), the red profile is the time average within the time interval (tfill,tall+tfill/2) using Eq. 7, and the blue one corresponds to the interval (tall+tfill/2,tall). The black profile is the mean of the two parts.

The information from all replicas is combined to evaluate the free energy along any CVs, ξ, using the weighted histogram analysis method (WHAM) (47,63,70):

G(ξ)=kBTln(iknξijke(fjVi(ξ))/kBT), (8)
Vi(ξ)=1talltfilltfilltalldtVGi(ξ,t), (9)

where k denotes the number of replicas, nξi is the number of times the system has the CV value ξ in replica i, VGi(ξ,t) is the biasing potential acting on the CV value ξ in replica i at time t, and fi represents constants to be determined via WHAM iterations. This method has been used to study protein folding as well as short amyloid fibril nucleation (47,48). In this study, we applied BE-Meta and WHAM to construct the conformational free energies of hIAPP derivatives along the αrmsd and anti-βrmsd CVs.

Peptide conformation and cluster analysis

By monitoring the peptide conformations within the αrmsd and anti-βrmsd space, we find that the peptide adopts primarily the α structure when αrmsd>3 and anti-βrmsd<4, the β structure when αrmsd<3 and anti-βrmsd>5, and the γ conformation when αrmsd<2 and anti-βrmsd<2. The free-energy difference between two conformations is thus given by

ΔGAB=GBGA=kBTln(ξBeG(ξ)/kBTξAeG(ξ)/kBT), (10)

where the free energy Gi of conformation i is evaluated by integrating the free energy G(ξ) of the region i in CV space ξ.

The peptide may adopt different structures in each conformational region. For example, if the peptide has an anti-βrmsd value of 10, the peptide can form one long antiparallel β-sheet or exhibit several short antiparallel β-strands. To characterize this structural multiplicity in each conformational region, we extracted all of the protein conformations within the region and performed principal component analysis (PCA) on the conformational ensemble (71,72). Based on the projection on the first two modes, the peptide conformations were grouped into clusters using the K-means algorithm (73). To characterize the structural similarity within each cluster, we averaged the observed structures within a cluster and calculated the RMSDs from that mean structure. The free-energy difference between two clusters, m and n, can be estimated by

ΔGmn=GmGn=kBTln(ΩmeG(ξΩ)/kBTΩneG(ξΩ)/kBT), (11)

where Ω is a conformation in cluster m or n and has CV values of ξΩ, and G(ξΩ) is the corresponding free energy of ξΩ. Combining PCA and Eq. 11, we further characterized different peptide conformations and their corresponding thermodynamic stability.

Results and Discussion

Human amylin

We used four CVs to sample the conformations of hIAPP: αrmsd, anti-βrmsd, and the native Cα contacts in the N-terminal α-helix and the β-hairpin structures proposed by Reddy et al. (43). The resulting free-energy surface along the αrmsd and anti-βrmsd is shown in Fig. 3 A. We find that the difference between the free-energy minima of the α and β conformations is −9.96 kJ/mol, which is lower than the −0.6 kJ/mol reported by Reddy et al. (43) for different CVs. Reddy et al. used the distance between two Cα carbons of a H-bonding pair residues in the folded structures as CVs. Under this definition, the unfolded state requires the H-bonding pair residues to exhibit large separation distances, which in turn implies more extended conformations of the molecule. In what follows, any local conformation with low αrmsd and anti-βrmsd values is considered to be unstructured. Note that such a definition for an unstructured coil is less restrictive than the one employed by Reddy et al. The anti-βrmsd CV runs over all possible 3+3 combinations among 37 residues of hIAPP, and thus is able to sample β-sheet conformations other than the one suggested by Reddy et al. To better estimate any free-energy differences, we integrated the free energies within each region and calculated the corresponding free energy using Eq. 10. Our results are listed in Table 1. The γ conformation, due to a large conformational ensemble in the defined CV region, exhibits the lowest free energy, namely 6.31 kJ/mol lower than the α conformation. The β conformation has a free energy that is 4.04 kJ/mol lower than the α conformation. Several conformations were observed in the β region. These conformations contribute to an overall low free energy of the β region on the free-energy surface shown in Fig. 3 A.

Figure 3.

Figure 3

(A) Free-energy surface of hIAPP along the αrmsd and anti- βrmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions defined for the α-helix, β-sheet, and random coil conformations are marked with purple, orange, and white rectangles. (B) The representative peptide conformation for the α-helical region is labeled with α. The five representative β conformations identified via PCA analysis are labeled as β1–β5. Also shown are the corresponding free energies and RMSDs from the mean structures of each conformation. The α-helical and β-sheet conformation are identified using the STRIDE algorithm, and are colored in dark purple and light yellow, respectively.Residues Ala-25, Ser-28, and Ser-29 are represented by a stick model colored in red, blue, and green, respectively. The images were generated using VMD (64). (C) For hIAPP, β-sheet segments along the peptide sequence in each β conformation are shown.

Table 1.

Free-energy difference of α, β, and γ conformations evaluated via Eq. 10 for hIAPP derivatives

α β γ
hIAPP −4.04 −6.31
Pramlintide 2.91 −1.76
A25P −2.93 −3.64
S28P+S29P −1.91 −2.03

The free-energy difference (kJ/mol) listed is relative to that of the α conformations.

To characterize the various β-sheet conformations that arise, we performed PCA on the peptide conformations corresponding to the β region. We identified five β-sheet-rich conformations, as illustrated in Fig. 3 B, all having average RMSDs ≤ 5.27 Å. Fig. 3 C shows the β-strands along the peptide sequence for each β conformation. Three of the structures (β1, β2, and β3) exhibit long β-hairpin conformations. The β1 hairpin is the same as that identified by Reddy et al. (43), where the turn region consists of residues 2023. The β2 conformation is similar to β1 but is shifted by one residue, with the turn region located at residues 1922. In the β3 conformation, the turn region is shifted toward the C-terminus and located at residues 2427, whereas the N-terminus generally folds into a short helix. The β4 structure is a collapsed form of β3 and consists of four short β-sheets with turn regions at residues 1821, 2427, and 3033. The β5 conformation is a four-fold β-sheet structure with three turn regions located at residues 1013, 1821, and 2831, respectively.

One of the most widely cited structures for the hIAPP mature fibril is the one proposed by Luca et al. (32) on the basis of ssNMR, which was further supported by EPR, 2DIR, and x-ray diffraction data (33–35). The β-strands in the U-shape fibril model are located at residues 817 and 2837, which are consistent with the β-strands observed in the β1 and β2 conformations reported here. Kajava et al. (31) proposed a three-fold β-strand amyloid model of hIAPP with three β-strands assigned to residues 1217, 2227, and 3137, a structure that is similar to the β5 conformation identified in this work.

As for the α region, the dominant conformation observed in our simulations is shown in Fig. 3 B: the N-terminus of the peptide (residues 1–18) forms an α-helix, and the rest of the molecule adopts an unstructured coil conformation. Due to the random conformation in the C-terminus, the RMSD for the α-helical conformation is 7.19 Å, which is larger than that of the β conformations. The free energy of each conformation can be estimated using Eq. 11. Every β conformation has a free energy that is lower than that of the α conformation. The β1 conformation is the most stable, consistent with the results reported by Reddy et al. (43). All five conformations contribute to an overall lower free energy in the β region than that of the α region. In the literature, the α-helical conformation of hIAPP is considered important for receptor binding, whereas the β-hairpin conformation is viewed as the misfolded state (26,27,43–45). The free-energy data presented here for the hIAPP monomer exhibit multiple folded β states, suggesting that various segments in hIAPP have the ability to form a β-sheet. This observation is consistent with experimental data on fibril formation with different hIAPP fragments (36,38–40).

Pramlintide

Pramlintide, or symlin, differs from hIAPP by three proline mutations at residues 25, 28, and 29, which are known to attenuate the propensity for fibrillization (15,20). We conducted BE-Meta using αrmsd and anti-βrmsd as CVs to sample its conformational space. The resulting free-energy profile as a function of αrmsd and anti-βrmsd is displayed in Fig. 4 A. Compared with hIAPP, pramlintide exhibits lower free energies in the α region and higher free energies in the β region. By simply comparing the free-energy minima, we find that the β conformation is 0.27 kJ/mol higher than the α conformation. After integrating the free energy of each region, as listed in Table 1, we find that the free-energy difference between the α-helix and the β-sheet conformation is 2.91 kJ/mol. This suggests that the three proline mutations do inhibit the formation of conformations rich in β-sheet content. In addition, according to the free-energy surface, pramlintide can adopt states with αrmsd>9, indicating that the proline residues also stabilize the α-helix at the N-terminus.

Figure 4.

Figure 4

(A) Free-energy surface of pramlintide along the αrmsd and anti-βrmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions defined for the α-helix, β-sheet, and random coil conformations are marked with purple, orange, and white rectangles. (B) The representative peptide conformation for the α-helical region and the three representative β conformations identified via PCA analysis are labeled as α and β1–β3, respectively, along with the corresponding free energies and RMSDs from the mean structures. Residues Pro-25, Pro-28, and Pro-29 are represented by a stick model colored in red, blue, and green, respectively. The structure color code is the same as in Fig. 3. (C) For pramlintide, β-sheet segments along the peptide sequence in each β conformation are shown.

Similar to the case with hIAPP, we performed PCA to characterize the pramlintide conformations in the β region. Three β conformations (β1, β2, and β3) were identified, as shown in Fig. 4 B, with RMSDs smaller than 6.14 Å. The β1 conformation has six short β strands, with the proline residues located at the turn regions. In the β2 conformation, the peptide forms a long antiparallel β-sheet, with segments containing no proline residues. The β3 structure consists of four adjacent antiparallel β strands, similar to the Greek key motif. As for the α region, one major conformation is observed in which the segment comprising residues 417 forms an α-helix and the rest of the peptide remains unstructured, similar to the hIAPP α conformation. Among the three β conformations, the most stable one, β1, has a free energy that is 2.55 kJ/mol higher than that of the α conformation, indicating that the helical conformation is the most stable folded structure of pramlintide. This again confirms that the three proline residues inhibit the formation of β-sheets and stabilize the α-helix. The β2 conformation has two β-strands consisting of segments 917 and 3136, which contain no proline residues. This observation also agrees with experimental data showing that hIAPP fragments of residues 1019 and 3037 exhibit amyloidogenic properties (38–40). Indeed, Green et al. (15) showed that although the three proline substitutions greatly attenuate fibril formation, pramlintide can still form small amounts of fibrils (and certainly more than rIAPP). These results are consistent with the existence of β-rich metastable conformations in pramlintide inferred from our simulations. Green et al. also showed that the three nonproline, rat-specific residues, i.e., Arg-18, Leu-23, and Val-26, modulate the fibril-forming kinetics, highlighting the importance of these residues in amyloid formation.

hIAPP[A25P] and hIAPP[S28P,S29P]

To examine the effects of proline mutations, we calculated the conformational free energies of hIAPP peptide with one mutation at Ala-25 (hIAPP[A25P]), as well as two mutations at Ser-28 and Ser-29 (hIAPP[S28P,S29P]). The free-energy surface along αrmsd and anti-βrmsd for hIAPP[A25P] is shown in Fig. 5 A. The free-energy differences among α, β, and γ conformations estimated via integration over distinct regions are listed in Table 1. The β conformation for A25P has a free energy that is −2.93 kJ/mol lower than the corresponding α conformation. Although the difference is smaller than that in hIAPP, the β conformation is still slightly more favorable. Fig. 5 B displays the six peptide conformations in the β region of the free-energy map, identified via PCA and cluster analysis. The most favorable β conformation, β1, is similar to the β3 conformation of hIAPP, with the turn region located at residues 2427. Its free energy is −4.06 kJ/mol lower than that of the α conformation. The other conformations, β2 and β3, consist of four to five short β-stands. The β4 conformation is a three-fold β-strand structure, whereas β5 and β6 exhibit four antiparallel β-strands. For conformations β1–β5, the Pro-25 residue is found at or near the turn region. Also, among the six β conformations, only β1 has a long hairpin. When contrasted with the three hairpin conformations observed in hIAPP, this finding suggests that proline indeed serves as a β-sheet breaker and attenuates long-β-sheet formation.

Figure 5.

Figure 5

(A) Free-energy surface of hIAPP[A25P] along the αrmsd and anti- βrmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions defined for α-helix, β-sheet, and random coil conformations are marked with purple, orange, and white rectangles. (B) The representative peptide conformation for the α-helical region and the six representative β conformations identified via PCA analysis are labeled as α and β1–β6, respectively, along with the corresponding free energies and RMSDs from the mean structures. Residues Pro-25, Ser-28, and Ser-29 are represented by a stick model colored in red, blue, and green, respectively. The structure color code is the same as in Fig. 3. (C) For hIAPP[A25P], β-sheet segments along the peptide sequence in each β conformation are shown.

The free-energy surface of hIAPP[S28P,S29P] as a function of αrmsd and antiβrmsd is shown in Fig. 6 A. As shown in Table 1, the β-sheet region has an overall free energy of −1.91 kJ/mol relative to the α-helical region. The reduction of the free-energy difference is more than that observed for hIAPP[A25P], suggesting that sequential mutations at Ser-28 and Ser-29 have a larger inhibiting effect on β-sheet formation for the hIAPP monomer. PCA and cluster analysis reveal two major β conformations for hIAPP[S28P,S29P], as shown in Fig. 6 B. The β1 conformation is a three-strand, antiparallel β-sheet conformation, similar to the β4 conformation of hIAPP[A25P]. The β2 conformation is the most stable for hIAPP[S28P,S29P], with a free energy of −4.08 kJ/mol relative to the α conformation. The β2 conformation is similar to the β3 structure of hIAPP and the β1 structure of hIAPP[A25P] in which the two proline mutations break the long β-hairpin into two pairs of antiparallel β-sheets. Although Pro-28 and Pro-29 suppress long-β-sheet formation, the two β conformations still have favorable free energies compared with the α-conformation. For both hIAPP[A25P] and hIAPP[S28P,S29P], the α-helical regions have one dominant α-conformation, in which residues 417 form an α-helix. Because the helical segment does not include the mutation sites investigated in this study, the α conformations for all mutated hIAPP monomers are similar to those found in wild-type hIAPP.

Figure 6.

Figure 6

(A) Free-energy surface of hIAPP[S28P,S29P] along the αrmsd and anti- βrmsd CVs. Contour lines are drawn every 5 kJ/mol. The regions defined for α-helix, β-sheet, and random coil conformations are marked with purple, orange, and white rectangles. (B) The representative peptide conformation for the α-helical region and the two representative β conformations identified via PCA analysis are labeled as α, β1, and β2, respectively, along with the corresponding free energies and RMSDs from the mean structures. Residues Ala-25, Pro-28, and Pro-29 are represented by a stick model colored in red, blue, and green, respectively. The structure color code is the same as in Fig. 3. (C) For hIAPP[S28P,S29P], β-sheet segments along the peptide sequence in each β conformation are shown.

Several experiments have suggested that amylin remains amyloidogenic upon single-residue proline mutations at residues 25, 28, or 29 (16,17). In addition, the amylin peptides corresponding to species having one or two prolines, such as degu (Pro-28 and Pro-29), cat (Pro-29), and hamster (Pro-25 and Pro-29; see Fig. 1), are known to develop islet amyloid deposits (11–14). Figs. 3–6 C shows the β-sheet segments along the peptide sequence in each β conformation for the hIAPP derivative. Due to their cyclic structural nature, proline residues are found in the turn regions or at the end of β-strands, acting as β-sheet breakers and inhibiting long-β-sheet formation. When different β-strand sequences are compared, the β4 and β5 conformations of hIAPP[A25P] and the β1 conformation of hIAPP[S28P,S29P] exhibit strong similarities to the three-strand amyloid model proposed by Kajava et al. (31). This observation suggests that hIAPP[A25P] and hIAPP[S28P,S29P] are able to retain some amyloidogenic characteristics. According to our free-energy results (Table 1), the β conformation becomes less favorable as proline mutations are introduced. The consecutive mutations at Ser-28 and Ser-29 have a greater effect than a single mutation at Ala-25 on β-sheet inhibition. However, the β conformations are still more favorable than the α conformations for both hIAPP derivatives. All three proline mutations in pramlintide are necessary to make the α conformation more thermodynamically stable than the β conformations. This observation agrees with experimental results on the amyloidogenic nature of variants of IAPP corresponding to different species. Our results show that the proline substitutions modulate the conformation of IAPP monomers because proline reduces the amyloidogenic tendency by suppressing β-sheet formation.

Conclusions

BE-Meta simulations were used to study the conformational space and the corresponding free energy of several mutants of IAPP, namely hIAPP, hIAPP[A25P], hIAPP[S28P, S29P], and pramlintide (hIAPP[A25P, S29P, S29P]). All four hIAPP derivatives were found to adopt multiple β-sheet conformations, unstructured coils, and one major α-helical conformation in which the N-terminus adopts an α-helical state. Several of the β-rich conformations observed here are consistent with previous experimental reports.

In one of the possible aggregation mechanisms of hIAPP, monomers can interconvert between native folded states, e.g., between the α and γ conformations and the β-rich conformations (43–45). The β-conformers can act as the amyloidogenic precursor by templating the folding of additional monomers, and promote self-assembly into small aggregates and subsequent fibril formation. The results presented here provide insights into the thermodynamic stability of distinct folded states, which could serve as precursors to fibril formation, and may be useful for developing therapeutic strategies aimed at inhibiting early-stage aggregation.

Our simulated free energies help explain the tendency for aggregation (or lack thereof) of the amylin peptides found in different species. For hIAPP, hIAPP[A25P], and hIAPP[S28P,S29P], the β-rich states exhibit lower free energies than the corresponding α-rich conformations. The [S28P,S29P] mutations are more effective than the A25P mutation at raising the free energy of the β-rich conformations. For pramlintide, where all three proline mutations are introduced, the α-helical conformation becomes more thermodynamically favorable than the β-rich conformations. Our combined results indicate that although [S28P,S29P] mutations are effective at reducing β-sheet formation, one really needs three mutations, namely [A25P, S29P, S29P], to eliminate hIAPP’s ability to aggregate.

Another possible aggregation mechanism of hIAPP involves the association of two hIAPP α-conformers into small nuclei (3,74). In future work, the methodology developed here will be applied to probe the effect of proline mutations on the dimerization of different hIAPP conformers and to explore the thermodynamics of nuclei formation.

Acknowledgments

The authors are grateful to James L. Skinner and Martin T. Zanni for fruitful discussions. This work was supported by the Office of Basic Energy Sciences, U.S. Department of Energy, under contract No. DE-AC02-06CH11357, and the National Institutes of Health under grant No. 1R01DK088184.

Supporting Material

Document S1. Supporting material, one figure, one table, and supporting references
mmc1.pdf (501.1KB, pdf)
Document S2. Article plus Supporting Material
mmc2.pdf (2.1MB, pdf)

References

  • 1.Westermark P., Andersson A., Westermark G.T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 2011;91:795–826. doi: 10.1152/physrev.00042.2009. [DOI] [PubMed] [Google Scholar]
  • 2.Hebda J.A., Miranker A.D. The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes. Annu. Rev. Biophys. 2009;38:125–152. doi: 10.1146/annurev.biophys.050708.133622. [DOI] [PubMed] [Google Scholar]
  • 3.Cao P., Abedini A., Raleigh D.P. Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology. Curr. Opin. Struct. Biol. 2013;23:82–89. doi: 10.1016/j.sbi.2012.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bell E.T. Hyalinization of the islet of Langerhans in diabetes mellitus. Diabetes. 1952;1:341–344. doi: 10.2337/diab.1.5.341. [DOI] [PubMed] [Google Scholar]
  • 5.Clark A., Cooper G.J., Turner R.C. Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet. 1987;2:231–234. doi: 10.1016/s0140-6736(87)90825-7. [DOI] [PubMed] [Google Scholar]
  • 6.Clark A., Wells C.A., Turner R.C. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 1988;9:151–159. [PubMed] [Google Scholar]
  • 7.Lorenzo A., Razzaboni B., Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994;368:756–760. doi: 10.1038/368756a0. [DOI] [PubMed] [Google Scholar]
  • 8.Westermark P., Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol. Microbiol. Scand. [A] 1973;81:291–300. doi: 10.1111/j.1699-0463.1973.tb03538.x. [DOI] [PubMed] [Google Scholar]
  • 9.Westermark P., Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia. 1978;15:417–421. doi: 10.1007/BF01219652. [DOI] [PubMed] [Google Scholar]
  • 10.Westermark P., Li Z.C., Steiner D.F. Effects of β cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett. 1996;379:203–206. doi: 10.1016/0014-5793(95)01512-4. [DOI] [PubMed] [Google Scholar]
  • 11.Howard C.F., Jr. Insular amyloidosis and diabetes mellitus in Macaca nigra. Diabetes. 1978;27:357–364. doi: 10.2337/diab.27.4.357. [DOI] [PubMed] [Google Scholar]
  • 12.Yano B.L., Hayden D.W., Johnson K.H. Feline insular amyloid: association with diabetes mellitus. Vet. Pathol. 1981;18:621–627. doi: 10.1177/030098588101800507. [DOI] [PubMed] [Google Scholar]
  • 13.Spear G.S., Caple M.V., Sutherland L.R. The pancreas in the degu. Exp. Mol. Pathol. 1984;40:295–310. doi: 10.1016/0014-4800(84)90047-9. [DOI] [PubMed] [Google Scholar]
  • 14.Betsholtz C., Christmansson L., Westermark P. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 1989;251:261–264. doi: 10.1016/0014-5793(89)81467-x. [DOI] [PubMed] [Google Scholar]
  • 15.Green J., Goldsbury C., Aebi U. Full-length rat amylin forms fibrils following substitution of single residues from human amylin. J. Mol. Biol. 2003;326:1147–1156. doi: 10.1016/s0022-2836(02)01377-3. [DOI] [PubMed] [Google Scholar]
  • 16.Westermark P., Engström U., Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. USA. 1990;87:5036–5040. doi: 10.1073/pnas.87.13.5036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Moriarty D.F., Raleigh D.P. Effects of sequential proline substitutions on amyloid formation by human amylin20-29. Biochemistry. 1999;38:1811–1818. doi: 10.1021/bi981658g. [DOI] [PubMed] [Google Scholar]
  • 18.Middleton C.T., Marek P., Zanni M.T. Two-dimensional infrared spectroscopy reveals the complex behaviour of an amyloid fibril inhibitor. Nat. Chem. 2012;4:355–360. doi: 10.1038/nchem.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Liang G., Zhao J., Zheng J. Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers. Biochemistry. 2013;52:1089–1100. doi: 10.1021/bi301525e. [DOI] [PubMed] [Google Scholar]
  • 20.McQueen J. Pramlintide acetate. Am. J. Health Syst. Pharm. 2005;62:2363–2372. doi: 10.2146/ajhp050341. [DOI] [PubMed] [Google Scholar]
  • 21.Ratner R.E., Dickey R., Kolterman O.G. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial. Diabet. Med. 2004;21:1204–1212. doi: 10.1111/j.1464-5491.2004.01319.x. [DOI] [PubMed] [Google Scholar]
  • 22.Ryan G.J., Jobe L.J., Martin R. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus. Clin. Ther. 2005;27:1500–1512. doi: 10.1016/j.clinthera.2005.10.009. [DOI] [PubMed] [Google Scholar]
  • 23.Jaikaran E.T., Clark A. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. Biochim. Biophys. Acta. 2001;1537:179–203. doi: 10.1016/s0925-4439(01)00078-3. [DOI] [PubMed] [Google Scholar]
  • 24.Kayed R., Bernhagen J., Kapurniotu A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 1999;287:781–796. doi: 10.1006/jmbi.1999.2646. [DOI] [PubMed] [Google Scholar]
  • 25.Saldanha J., Mahadevan D. Molecular model-building of amylin and α-calcitonin gene-related polypeptide hormones using a combination of knowledge sources. Protein Eng. 1991;4:539–544. doi: 10.1093/protein/4.5.539. [DOI] [PubMed] [Google Scholar]
  • 26.Knight J.D., Hebda J.A., Miranker A.D. Conserved and cooperative assembly of membrane-bound α-helical states of islet amyloid polypeptide. Biochemistry. 2006;45:9496–9508. doi: 10.1021/bi060579z. [DOI] [PubMed] [Google Scholar]
  • 27.Nanga R.P.R., Brender J.R., Ramamoorthy A. Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J. Am. Chem. Soc. 2009;131:8252–8261. doi: 10.1021/ja9010095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Patil S.M., Xu S., Alexandrescu A.T. Dynamic α-helix structure of micelle-bound human amylin. J. Biol. Chem. 2009;284:11982–11991. doi: 10.1074/jbc.M809085200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Williamson J.A., Miranker A.D. Direct detection of transient α-helical states in islet amyloid polypeptide. Protein Sci. 2007;16:110–117. doi: 10.1110/ps.062486907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cort J.R., Liu Z., Andersen N.H. Solution state structures of human pancreatic amylin and pramlintide. Protein Eng. Des. Sel. 2009;22:497–513. doi: 10.1093/protein/gzp029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kajava A.V., Aebi U., Steven A.C. The parallel superpleated β-structure as a model for amyloid fibrils of human amylin. J. Mol. Biol. 2005;348:247–252. doi: 10.1016/j.jmb.2005.02.029. [DOI] [PubMed] [Google Scholar]
  • 32.Luca S., Yau W.-M., Tycko R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry. 2007;46:13505–13522. doi: 10.1021/bi701427q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wang L., Middleton C.T., Skinner J.L. 2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure. J. Am. Chem. Soc. 2011;133:16062–16071. doi: 10.1021/ja204035k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bedrood S., Li Y., Langen R. Fibril structure of human islet amyloid polypeptide. J. Biol. Chem. 2012;287:5235–5241. doi: 10.1074/jbc.M111.327817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wiltzius J.J.W., Sievers S.A., Eisenberg D. Atomic structure of the cross-β spine of islet amyloid polypeptide (amylin) Protein Sci. 2008;17:1467–1474. doi: 10.1110/ps.036509.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Glenner G.G., Eanes E.D., Wiley C.A. Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. Biochem. Biophys. Res. Commun. 1988;155:608–614. doi: 10.1016/s0006-291x(88)80538-2. [DOI] [PubMed] [Google Scholar]
  • 37.Asai J., Nakazato M., Matsuo H. Isolation and sequence determination of rat islet amyloid polypeptide. Biochem. Biophys. Res. Commun. 1989;164:400–405. doi: 10.1016/0006-291x(89)91733-6. [DOI] [PubMed] [Google Scholar]
  • 38.Jaikaran E.T., Higham C.E., Fraser P.E. Identification of a novel human islet amyloid polypeptide β-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 2001;308:515–525. doi: 10.1006/jmbi.2001.4593. [DOI] [PubMed] [Google Scholar]
  • 39.Tracz S.M., Abedini A., Raleigh D.P. Role of aromatic interactions in amyloid formation by peptides derived from human Amylin. Biochemistry. 2004;43:15901–15908. doi: 10.1021/bi048812l. [DOI] [PubMed] [Google Scholar]
  • 40.Nilsson M.R., Raleigh D.P. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J. Mol. Biol. 1999;294:1375–1385. doi: 10.1006/jmbi.1999.3286. [DOI] [PubMed] [Google Scholar]
  • 41.Abedini A., Raleigh D.P. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? J. Mol. Biol. 2006;355:274–281. doi: 10.1016/j.jmb.2005.10.052. [DOI] [PubMed] [Google Scholar]
  • 42.Reddy A.S., Wang L., De Pablo J.J. Solution structures of rat amylin peptide: simulation, theory, and experiment. Biophys. J. 2010;98:443–451. doi: 10.1016/j.bpj.2009.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Reddy A.S., Wang L., de Pablo J.J. Stable and metastable states of human amylin in solution. Biophys. J. 2010;99:2208–2216. doi: 10.1016/j.bpj.2010.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dupuis N.F., Wu C., Bowers M.T. Human islet amyloid polypeptide monomers form ordered β-hairpins: a possible direct amyloidogenic precursor. J. Am. Chem. Soc. 2009;131:18283–18292. doi: 10.1021/ja903814q. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Dupuis N.F., Wu C., Bowers M.T. The amyloid formation mechanism in human IAPP: dimers have β-strand monomer-monomer interfaces. J. Am. Chem. Soc. 2011;133:7240–7243. doi: 10.1021/ja1081537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Piana S., Laio A. A bias-exchange approach to protein folding. J. Phys. Chem. B. 2007;111:4553–4559. doi: 10.1021/jp067873l. [DOI] [PubMed] [Google Scholar]
  • 47.Marinelli F., Pietrucci F., Piana S. A kinetic model of trp-cage folding from multiple biased molecular dynamics simulations. PLOS Comput. Biol. 2009;5:e1000452. doi: 10.1371/journal.pcbi.1000452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Baftizadeh F., Biarnes X., Laio A. Multidimensional view of amyloid fibril nucleation in atomistic detail. J. Am. Chem. Soc. 2012;134:3886–3894. doi: 10.1021/ja210826a. [DOI] [PubMed] [Google Scholar]
  • 49.Oostenbrink C., Villa A., van Gunsteren W.F. A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6. J. Comput. Chem. 2004;25:1656–1676. doi: 10.1002/jcc.20090. [DOI] [PubMed] [Google Scholar]
  • 50.Berendsen H., Postma J., Van Gunsteren W.F. Intercation models for water in relation to protein hydration. In: Pullman B., editor. Intermolecular Forces. Reidel; Dordrecht: 1981. pp. 331–332. [Google Scholar]
  • 51.Mark P., Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J. Phys. Chem. A. 2001;105:9954–9960. [Google Scholar]
  • 52.Darden T., York D., Pedersen L. Particle mesh Ewald—an N.Log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089–10092. [Google Scholar]
  • 53.Essmann U., Perera L., Pedersen L.G. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577–8593. [Google Scholar]
  • 54.Hess B., Bekker H., Fraaije J. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 1997;18:1463–1472. doi: 10.1021/ct700200b. [DOI] [PubMed] [Google Scholar]
  • 55.Nose S. A molecular-dynamics method for simulations in the canonical ensemble. Mol. Phys. 1984;52:255–268. [Google Scholar]
  • 56.Nose S. A unified formulation of the constant temperature molecular-dynamics methods. J. Chem. Phys. 1984;81:511–519. [Google Scholar]
  • 57.Hoover W.G. Canonical dynamics: equilibrium phase-space distributions. Phys. Rev. A. 1985;31:1695–1697. doi: 10.1103/physreva.31.1695. [DOI] [PubMed] [Google Scholar]
  • 58.Parrinello M., Rahman A. Polymorphic transitions in single-crystals—a new molecular-dynamics method. J. Appl. Phys. 1981;52:7182–7190. [Google Scholar]
  • 59.Hess B., Kutzner C., Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory Comput. 2008;4:435–447. doi: 10.1021/ct700301q. [DOI] [PubMed] [Google Scholar]
  • 60.Pietrucci F., Laio A. A collective variable for the efficient exploration of protein β-sheet structures: application to SH3 and GB1. J. Chem. Theory Comput. 2009;5:2197–2201. doi: 10.1021/ct900202f. [DOI] [PubMed] [Google Scholar]
  • 61.Frishman D., Argos P. Knowledge-based protein secondary structure assignment. Proteins. 1995;23:566–579. doi: 10.1002/prot.340230412. [DOI] [PubMed] [Google Scholar]
  • 62.Bonomi M., Branduardi D., Parrinello M. PLUMED: a portable plugin for free-energy calculations with molecular dynamics. Comput. Phys. Commun. 2009;180:1961–1972. [Google Scholar]
  • 63.Biarnes X., Pietrucci F., Laio A. METAGUI. A VMD interface for analyzing metadynamics and molecular dynamics simulations. Comput. Phys. Commun. 2012;183:203–211. [Google Scholar]
  • 64.Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J. Mol. Graphics. 1996;14:33–38. doi: 10.1016/0263-7855(96)00018-5. 27–28. [DOI] [PubMed] [Google Scholar]
  • 65.Laio A., Parrinello M. Escaping free-energy minima. Proc. Natl. Acad. Sci. USA. 2002;99:12562–12566. doi: 10.1073/pnas.202427399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Berg B.A., Neuhaus T. Multicanonical ensemble: a new approach to simulate first-order phase transitions. Phys. Rev. Lett. 1992;68:9–12. doi: 10.1103/PhysRevLett.68.9. [DOI] [PubMed] [Google Scholar]
  • 67.Yan Q., de Pablo J.J. Hyperparallel tempering Monte Carlo simulation of polymeric systems. J. Chem. Phys. 2000;113:1276. [Google Scholar]
  • 68.Singh S., Chopra M., de Pablo J.J. Density of states-based molecular simulations. Annu Rev Chem Biomol Eng. 2012;3:369–394. doi: 10.1146/annurev-chembioeng-062011-081032. [DOI] [PubMed] [Google Scholar]
  • 69.Laio A., Gervasio F.L. Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science. Rep. Prog. Phys. 2008;71:126601. [Google Scholar]
  • 70.Kumar S., Rosenberg J.M., Kollman P.A. The weighted histogram analysis method for freeenergy calculations on biomolecules. I. The method. J. Comput. Chem. 1992;13:1011–1021. [Google Scholar]
  • 71.García A.E. Large-amplitude nonlinear motions in proteins. Phys. Rev. Lett. 1992;68:2696–2699. doi: 10.1103/PhysRevLett.68.2696. [DOI] [PubMed] [Google Scholar]
  • 72.Levy R.M., Srinivasan A.R., McCammon J.A. Quasi-harmonic method for studying very low frequency modes in proteins. Biopolymers. 1984;23:1099–1112. doi: 10.1002/bip.360230610. [DOI] [PubMed] [Google Scholar]
  • 73.MacQueen J. University of California Press; Berkeley, CA: 1967. Some Methods for Classification and Analysis of Multivariate Observations. [Google Scholar]
  • 74.Wiltzius J.J.W., Sievers S.A., Eisenberg D. Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Sci. 2009;18:1521–1530. doi: 10.1002/pro.145. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Supporting material, one figure, one table, and supporting references
mmc1.pdf (501.1KB, pdf)
Document S2. Article plus Supporting Material
mmc2.pdf (2.1MB, pdf)

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES